About Invent Bio
Invent Bio is a company based in Andheri (India) founded in 2005 by Ravi Shankar Srivastava. It operates as a B2B. Invent Bio has raised $792.77 thousand across 3 funding rounds from investors including Ladderup, Murgesan Madurai Veeran Devendran and Zang Qui. The company has 15 employees as of March 31, 2018. Invent Bio operates in a competitive market with competitors including Silk Road Medical, HDL Therapeutics, Lifetech Scientific Corporation, Supira Medical and Shanghai Baixin'an Biotechnology, among others.
- Headquarter Andheri, India
- Employees 15 as on 31 Mar, 2018
- Founders Ravi Shankar Srivastava
- Stage Minicorn
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Invent Bio-Med Private Limited
- Date of Incorporation 03 May, 2005
-
Annual Revenue
$562.95 K (USD)0as on Mar 31, 2018
-
Net Profit
-$939.59 K (USD)0as on Mar 31, 2018
-
EBITDA
-$501.38 K (USD)0as on Mar 31, 2018
-
Total Equity Funding
$792.77 K (USD)
in 3 rounds
-
Latest Funding Round
$44.02 K (USD), Angel Round
Feb 23, 2011
-
Investors
Ladderup
& 15 more
-
Employee Count
15
as on Mar 31, 2018
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Invent Bio
Invent Bio has successfully raised a total of $792.77K across 3 strategic funding rounds. The most recent funding activity was a Angel Round of $44.02 thousand completed in February 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Invent Bio
Invent Bio has secured backing from 16 investors, including angel and institutional investors. Prominent investors backing the company include Ladderup, Murgesan Madurai Veeran Devendran and Zang Qui.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Boutique investment bank focused on middle market
|
Locked | Locked | Locked | |
|
MM
Murgesan Madurai Veeran Devendran |
-
|
Locked | Locked | Locked |
|
ZQ
Zang Qui |
-
|
Locked | Locked | Locked |
Investor details for Invent Bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Invent Bio
Investment portfolio details for Invent Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Invent Bio
Detailed financials for Invent Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Invent Bio Comparisons
Peer comparison for Invent Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Invent Bio
Invent Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Silk Road Medical, HDL Therapeutics, Lifetech Scientific Corporation, Supira Medical and Shanghai Baixin'an Biotechnology, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of neuroprotection devices for carotid artery disease
|
|
| Locked | Locked | Locked |
Therapy to reverse coronary atherosclerosis is developed using patient plasma.
|
|
| Locked | Locked | Locked |
Interventional devices for cardiovascular and vascular diseases are developed.
|
|
| Locked | Locked | Locked |
Developer of ventricular assist devices for coronary intervention and cardiogenic shock
|
|
| Locked | Locked | Locked |
A bioabsorbable coronary rapamycin-eluting stent system is developed using PLLA.
|
|
| Locked | Locked | Locked |
Pulsatile intravascular lithotripsy is developed for calcified arterial disease treatment.
|
Detailed competitors of Invent Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Invent Bio
Complete news archive for Invent Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Invent Bio
Invent Bio was founded in 2005 and raised its 1st funding round 2 years after it was founded.
Invent Bio is headquartered in Andheri, India. It is registered at Andheri, Maharashtra, India.
Invent Bio is a funded company, having raised a total of $792.77K across 3 funding rounds to date.
As of Mar 31, 2018, the latest employee count at Invent Bio is 15.
Annual revenue of Invent Bio is $562.95K as on Mar 31, 2018.
Invent Bio provides a portfolio of interventional cardiovascular medical devices, focusing on providing healthcare solutions, developing medical devices, cardiovascular, and interventional devices. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.
Invent Bio's top competitors include Silk Road Medical, Lifetech Scientific Corporation and InterShunt Technologies.
Invent Bio has 16 investors. Key investors include Ladderup, Murgesan Madurai Veeran Devendran, Zang Qui, Praful Parikh, and Nivedita Ravishankar Srivastava.
The valuation of Invent Bio is $2.93M as of Feb 2011.